Aptose Biosciences Inc.
APTOF$4M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaTORONTO13 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Nov 15, 2026
36wMarket Overview
Stock performance and key metrics
APTOF News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Virulizin®
Pancreatic Cancer
GTI-2040
Acute Myeloid Leukemia
Tuspetinib
Leukemia, Myeloid, Acute
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Virulizin® | Phase 3 | Pancreatic Cancer | - | - |
GTI-2040 | Phase 2 | Acute Myeloid Leukemia | - | - |
Tuspetinib | Phase 2 | Leukemia, Myeloid, Acute | - | - |
Pancreatic Cancer
1 drug in this indication
Acute Myeloid Leukemia
1 drug in this indication
Leukemia, Myeloid, Acute
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply